Clinical trial

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

NCT06699056

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2024-11-21

PhaseN/A

Study timeline

Study start (actual)2024-11-21Date precision: day

Registry last updated2026-06-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Ventricular Ejection Fractionunresolved

LVFunresolved

LV Dysfunctionunresolved

Atrial Enlargementunresolved

Conduction Defectunresolved

Heart Failureunresolved

Valvular Heart Diseaseunresolved

Ischemic Heart Diseaseunresolved

Cardiotoxicityunresolved

Myocardial Infarctionunresolved

Dilated Cardiomyopathyunresolved

HFrEF - Heart Failure With Reduced Ejection Fractionunresolved

HFpEF - Heart Failure With Preserved Ejection Fractionunresolved

Syncopeunresolved

Remodeling, Cardiacunresolved

Interventions

15-minutes of sitting during COR ECG AcquistionDEVICE

Sponsors & collaborators

Peerbridge Health, Inclead sponsor

Mapped research locations

New YorkNew York, United States1 DetroitMichigan, United States1 AustinTexas, United States1 OrangeCalifornia, United States1 GreensboroNorth Carolina, United States1 HackensackNew Jersey, United States1 PasadenaCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06699056 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.